microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)

Peter N Alexandrov1, Prerna Dua, James M Hill

  • 1Russian Academy of Medical Sciences Moscow 113152, Russia.

Insights

Alzheimer's disease (AD) shows increased levels of specific microRNAs (miRNAs) in cerebrospinal fluid (CSF) and brain extracellular fluid (ECF). These NF-κB-sensitive miRNAs may drive inflammatory neurodegeneration in the central nervous system (CNS).

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Cerebrospinal fluid (CSF) composition offers insights into brain disease biomarkers.
  • Alzheimer's disease (AD) is characterized by complex pathological changes in the brain.

Purpose of the Study:

  • To analyze amyloid beta (Aβ) peptide and microRNA (miRNA) abundance in CSF and extracellular fluid (ECF) from AD patients.
  • To investigate the role of specific miRNAs in AD pathogenesis and neuroinflammation.

Main Methods:

  • Analysis of Aβ peptide and miRNA levels in human CSF and brain ECF using miRNA-array and LED-Northern assays.
  • Co-culture experiments with human neuronal-glial (HNG) cells exposed to AD-derived ECF.
  • Treatment of HNG cells with anti-NF-κB agents to assess miRNA regulation.

Main Results:

  • A trend for decreased Aβ42 abundance was observed in AD CSF and ECF, but not statistically significant.
  • Significant increases in specific miRNAs (miRNA-9, miRNA-125b, miRNA-146a, miRNA-155) were found in AD CSF and ECF.
  • AD-derived ECF induced up-regulation of these miRNAs in HNG cells, which was inhibited by anti-NF-κB agents.

Conclusions:

  • Specific miRNAs (miRNA-9, miRNA-125b, miRNA-146a, miRNA-155) are elevated in AD CSF and ECF.
  • These miRNAs are NF-κB-sensitive and pro-inflammatory, suggesting a role in AD-associated neuroinflammation.
  • Enrichment of these miRNAs in CSF and ECF may contribute to the spread of pathogenic signaling in the CNS.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...